Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19

    NEXT STORY
    Myriad Announces New Studies Validating the Ability of Myriad’s riskScore® Test to Modify Breast Cancer Risk Prediction
    PREV STORY
    Reata Announces Promotion and New Hires For Key Leadership Roles
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Update: Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens

    author_avatar
    NASDAQ Market News

    Precipio Enters India Liquid Biopsy Market with Adoption by Leading Laboratory

    NEW HAVEN, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostic company Precipio, Inc. ...

    author_avatar
    NASDAQ Market News

    Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

    NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), ...

    author_avatar
    NASDAQ Market News